Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fagerlin, A.
Right arrow Articles by Ubel, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fagerlin, A.
Right arrow Articles by Ubel, P. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Cure Me Even If It Kills Me: Preferences for Invasive Cancer Treatment

Angela Fagerlin, PhD

VA Health Services Research & Development Center of Excellence, VA Ann Arbor Healthcare System, Ann Arbor, MI, Division of General Internal Medicine, University of Michigan, Ann Arbor, Center for Behavioral and Decision Sciences in Medicine, Ann Arbor, MI, fagerlin{at}med.umich.edu

Brian J. Zikmund-Fisher, PhD

VA Health Services Research & Development Center of Excellence, VA Ann Arbor Healthcare System, Ann Arbor, MI, Division of General Internal Medicine, University of Michigan, Ann Arbor, Center for Behavioral and Decision Sciences in Medicine, Ann Arbor, MI

Peter A. Ubel, MD

VA Health Services Research & Development Center of Excellence, VA Ann Arbor Healthcare System, Ann Arbor, MI, Division of General Internal Medicine, University of Michigan, Ann Arbor, Center for Behavioral and Decision Sciences in Medicine, Ann Arbor, MI, Department of Psychology, University of Michigan, Ann Arbor

Purpose. When making medical decisions, people often care not only about what happens but also about whether the outcome was a result of actions voluntarily taken or a result of inaction. This study assessed the proportion of people choosing nonoptimal treatments (treatments which reduced survival chances) when presented with hypothetical cancer scenarios which varied by outcome cause. Methods. A randomized survey experiment tested preferences for curing an existent cancer with 2 possible treatments (medication or surgery) and 2 effects of treatment (beneficial or harmful). Participants were 112 prospective jurors in the Philadelphia County Courthouse and 218 visitors to the Detroit-Wayne County Metropolitan Airport. Results. When treatment was beneficial, 27% of participants rejected medication, whereas only 10% rejected surgery with identical outcomes ( 2 = 5.87, P < 0.02). When treatment was harmful, participants offered surgery were significantly more inclined to take action (65% v. 38%, 2 = 11.40, P = 0.001), even though doing so reduced overall survival chances. Conclusions. Faced with hypothetical cancer diagnoses, many people say they would pursue treatment even if doing so would increase their chance of death. This tendency toward active treatment is notably stronger when the treatment offered is surgery instead of medication. Our study suggests that few people can imagine standing by and doing nothing after being diagnosed with cancer, and it should serve to remind clinicians that, for many patients, the best treatment alternative may not only depend on the medical outcomes they can expect to experience but also on whether those outcomes are achieved actively or passively.

Key Words: MeSH • omission bias • decision-making • survey • cancer

Medical Decision Making, Vol. 25, No. 6, 614-619 (2005)
DOI: 10.1177/0272989X05282639


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
T. Salz and N. T. Brewer
Offering Chemotherapy and Hospice Jointly: One Solution to Hospice Underuse
Med Decis Making, July 1, 2009; 29(4): 521 - 531.
[Abstract] [PDF]


Home page
Health Aff (Millwood)Home page
J. Graham and J. Hu
The Risk-Benefit Balance In The United States: Who Decides?
Health Aff., May 1, 2007; 26(3): 625 - 635.
[Abstract] [Full Text] [PDF]